Down-regulation of A3 ARs using siRNA and the application of A3 AR antagonists have been shown to diminish chemoresistance to paclitaxel, consequently promoting natural cell death in glioblastoma cells [117]. The gene discussed is ADORA3; the disease is glioblastoma.